Skip to main content
BIOPHARMA CREDIT PLC logo

BIOPHARMA CREDIT PLC — Investor Relations & Filings

Ticker · BPCR ISIN · GB00BDGKMY29 LEI · 213800AV55PYXAS7SY24 IL Financial and insurance activities
Open in API
Filings indexed 733 across all filing types
Latest filing 2026-02-20 Net Asset Value
Country GB United Kingdom
Listing IL BPCR

About BIOPHARMA CREDIT PLC

https://bpcruk.com/

BioPharma Credit PLC is a specialist investment trust that provides debt capital to the life sciences industry. The company's primary objective is to generate long-term, sustainable income for shareholders by investing in a diversified portfolio of interest-bearing debt assets. These investments are typically secured by royalties, revenue streams, and other cash flows derived from approved pharmaceutical products and healthcare technologies. This strategy offers investors exposure to the life sciences sector through debt instruments while providing financing to companies for growth and development.

Recent filings

Filing Released Lang Actions
Net Asset Value(s) and Monthly Factsheet
Net Asset Value Classification · 100% confidence The document is a short announcement (under 1,500 characters) issued via the London Stock Exchange's RNS service. It explicitly states the unaudited net asset value (NAV) per share for BioPharma Credit PLC as of 31 January 2026. Since it is a regular update of the Net Asset Value, it fits the NAV category.
2026-02-20 English
Dividend Declaration
Notice of Dividend Amount Classification · 100% confidence The document is an announcement from BioPharma Credit PLC declaring an interim dividend for the quarterly period ending 31 December 2025. It specifies the dividend amount, payment date, ex-dividend date, and details about dividend currency election. The document does not contain financial statements or detailed financial analysis but focuses solely on the dividend declaration and related shareholder information. The length is under 5,000 characters and it is a formal announcement of dividend amounts and payment details. Therefore, it fits the category of Notice of Dividend Amount (DIV) rather than a full financial report or other filing types.
2026-02-10 English
Notice of Full Year Results
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 5,000 characters) from BioPharma Credit PLC notifying the market of the upcoming release date for its audited Full Year Results. It does not contain the financial results themselves, but rather serves as a 'menu' item announcing the future publication of the 'meal'. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2026-02-03 English
Net Asset Value(s) and Monthly Factsheet
Net Asset Value Classification · 100% confidence The document is a short announcement (under 1,500 characters) issued via RNS (Regulatory News Service) that provides the unaudited net asset value (NAV) per share for BioPharma Credit PLC as of December 31, 2025. Since it is a periodic update specifically reporting the NAV figure, it falls under the Net Asset Value category.
2026-01-23 English
STATEMENT RE COLLEGIUM PREPAYMENT
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement regarding a specific financial event: the prepayment of a loan by Collegium Pharmaceutical, Inc. to BioPharma Credit PLC. It details the financial impact of this prepayment on the company's cash balance and provides commentary from the investment manager. Since it is a specific corporate announcement regarding financing/capital activity and does not fit into more specific categories like 'Share Issue' or 'Dividend', it is classified as a Regulatory Filing (RNS).
2025-12-30 English
Net Asset Value(s) and Monthly Factsheet
Net Asset Value Classification · 100% confidence The document is a short announcement from BioPharma Credit PLC reporting the unaudited net asset value (NAV) per share as of 30 November 2025. It is distributed via the London Stock Exchange's RNS service. Since the primary purpose is to disclose the specific NAV figure, it falls under the Net Asset Value (NAV) category.
2025-12-19 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.